Sign in
Taking people in United StatesNo phase

Studies why weight loss stalls in adults with obesity

Tests a behavioral weight loss program to study body and brain changes.

Key facts

Who runs it
University of Washington
Where
Seattle, United StatesSee the 2 sites
Trial code
Registry title
ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)
Status
Recruiting
People taking part
90 people, planned
Started
1 Oct 2023
Expected to end
31 Jul 2027
Type of study
Interventional
Treatments tested
  • Behavioral Weight Loss Program
Record updated
29 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 60 with obesity (BMI 30.0 to 50.0 kg/m2) who can attend classes and visits. It studies why weight loss stops during a weight loss program.

Age
18 to 60 years
Sex
All sexes can join.
Disease stage
BMI 30.0 to 50.0 kg/m2.
Earlier treatment
People cannot join if they are in a formal weight loss program now, took part in a weight loss research study before, had bariatric surgery, or lost more than 10% of their weight in the past year.

Main reasons for not taking part

  • Type 2 diabetes
  • Current smoker, regular nicotine or cannabis use, or heavy alcohol or drug use
  • Currently pregnant, 6 months postpartum after a full-term pregnancy, or breastfeeding
  • Weight over 330 pounds (150 kg), or a reason an MRI cannot be done
  • History of eating disorder, stroke or known cognitive problems

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • BMI 30.0 - 50.0 kg/m2
  • Able to attend study intervention classes and study visits/assessments
  • Independently living with access to food preparation facilities

Who cannot take part

  • Heavy alcohol use (≥2 drinks/d for females, ≥3 drinks/d for males) or drug use
  • Use of medications with significant effects on appetite (e.g., weight loss medications, atypical antipsychotics, stimulants) and/or chronic use of anticoagulants
  • Prior or current participation in a research study involving weight loss
  • Known cognitive impairments or h/o stroke
  • Type 2 diabetes (known diagnosis or by screening A1c (≥6.5%))
  • Medical conditions (chronic diseases, cancer, MS) or labs limiting ability to participate
  • History of bariatric surgery
  • History of eating disorder
  • Allergy or intolerance to or unwillingness to consume study foods provided at visit
  • Any condition(s) found by the study team and confirmed with the PI(s) that make it unsafe to participate
  • Current smoker or regular use of nicotine containing products and/or cannabis
  • Females: currently pregnant (or 6-months postpartum of full-term pregnancy) and/or current breastfeeding
  • Current participation in a formal weight loss program
  • Weight-reduced by >10% within past year
  • Weight > 330 pounds (MRI limit)
  • MRI contraindication (e.g., implanted metal, claustrophobia)
  • Do not have a phone compatible with activity tracker or access to videoconferencing platform that will be used for the dietary intervention or other appropriate technology needed to complete study procedures

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where in United States

  • Fred Hutch Cancer CenterSeattle, United StatesContact: Diana LowryNot yet recruiting
  • University of Washington - South Lake UnionSeattle, United StatesContact: Mary WebbTaking people

About the trial

What the trial wants to find out

Behavioral weight loss programs for obesity can result in weight loss and health benefits. However, behavioral weight loss often stops despite efforts to continue losing weight, this can be called an involuntarily weight loss plateau. This study investigates changes in metabolism and/or the brain that contribute to the occurrence of an involuntary weight loss plateau.

The group in the trial

  • Behavioral Weight LossTreatment being tested

    Participants will undergo a behavioral weight loss program.

    Treatment: Behavioral Weight Loss Program

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Physiological Changes Underlying the Weight Loss Plateau in Human
Plain-language title
Studies why weight loss stalls in adults with obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06174389, who can take part
Publications
Record updated
29 August 2025